Aegis Initiates Coverage on Cogentix Medical (CGNT)
Investment analysts at Aegis assumed coverage on shares of Cogentix Medical (NASDAQ:CGNT) in a report released on Friday, The Fly reports. The firm set a “buy” rating on the medical device company’s stock.
Other equities analysts also recently issued research reports about the company. Zacks Investment Research upgraded Cogentix Medical from a “hold” rating to a “buy” rating and set a $2.50 target price on the stock in a research note on Friday, August 4th. TheStreet upgraded Cogentix Medical from a “d+” rating to a “c” rating in a research note on Thursday, November 9th. Roth Capital started coverage on Cogentix Medical in a research note on Wednesday, November 8th. They set a “buy” rating and a $4.00 price objective on the stock. Finally, JMP Securities started coverage on Cogentix Medical in a research note on Friday, October 6th. They set an “outperform” rating and a $5.00 price objective on the stock. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company’s stock. Cogentix Medical presently has an average rating of “Buy” and an average price target of $3.83.
Shares of Cogentix Medical (NASDAQ:CGNT) opened at $2.86 on Friday. Cogentix Medical has a 1 year low of $1.55 and a 1 year high of $3.26.
ILLEGAL ACTIVITY WARNING: This news story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international trademark & copyright laws. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/12/01/aegis-initiates-coverage-on-cogentix-medical-cgnt.html.
About Cogentix Medical
Cogentix Medical, Inc is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB).
Receive News & Ratings for Cogentix Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cogentix Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.